Active-ingredient Dossier
Fluoxetine Hydrochloride
Active-ingredient Dossier for Fluoxetine Hydrochloride (selective serotonin reuptake inhibitor). Australian brands, products, PBS listings, PBAC outcomes…
- Brand: ZACTIN
- Brand: FLUOXETINE
- Brand: FLUOXETINE
- Brand: FLUOXETINE-WGR
- Brand: PHARMACOR
- Brand: BTC
- Therapeutic area: Psychiatry
What is
Fluoxetine Hydrochloride Fluoxetine Hydrochloride is a selective serotonin reuptake inhibitor.
Australian brands containing
Fluoxetine Hydrochloride — FLUOTEX — ZACTIN — APO-FLUOXETINE — FLUOXETINE — FLUOXETINE-WGR
Therapeutic areas
Fluoxetine Hydrochloride is registered in neurology (8 brands) and psychiatry (1 brand).
Sponsor landscape
The ingredient is marketed by six sponsors: Arrotex Pharmaceuticals, Alphapharm, Generic Health, Medsurge Pharma, Sandoz, and GM Pharma.
PBS and regulatory activity
Two brands containing Fluoxetine Hydrochloride have PBS-listed items, with the latest PBS schedule date being 1 May 2026.